Global Cell Therapy Manufacturing Market, By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies), By Source of Cell (Autologous v/s Allogenic), By Scale of Operation (Preclinical, Clinical, Commercial), By Source (In-House v/s Contract Manufacturing), By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), By Region, Competition Forecast and Opportunities, 2026
Global cell therapy manufacturing market was valued at USD3123.44 million in the year 2020 and is anticipated to grow with a CAGR value of 12.0% in the forecast period, 2022-2026 to reach market value of USD6015.09 million by 2026F. The market growth can be attributed to advancing biopharmaceutical industries across the globe. Moreover, increasing dependency on cell therapy and thus therapeutics & pharmaceutical products for the efficient treatment of the patients suffering from critical diseases and conditions is also supporting the growth of the global cell therapy manufacturing market in the next five years. Additionally, growing prevalence of chronic diseases like cardiovascular diseases, cancer disease, along with lifestyle diseases like obesity, diabetes that further deteriorates immunity of the humans further contributes to the growth of the global cell therapy manufacturing market in the future five years. Recent instance of COVID-19 outbreak that caused millions of deaths worldwide has created a demand for advanced cell therapy manufacturing to devise pharmaceuticals, vaccines, etc. Significant development and advancement in cell-based therapies for skin rejuvenation and tendon regeneration are further driving the growth of the global cell therapy manufacturing market in the forecast period.
The global cell therapy manufacturing market is segmented by therapy, source of cell, scale of operation, source, application, end user, company, and regional distribution. Based on application, the market is further divided into oncology, cardiovascular diseases, orthopedic diseases, and others. Oncology sub-segment is anticipated to hold more than 50% of the revenue shares of the market and dominate the application based market segmentation in the upcoming five years. The growth can be attributed to increasing instances of various types of cancer in the global population. Moreover, increased technological advancement and consistent cell therapy based research for the treatment of cancer is further anticipated to support the market growth.
Novartis AG, F. Hoffmann-La Roche AG, Gilead Sciences, Inc., Thermo Fischer Scientific, Inc., Catalent, Inc., JSR Life Sciences LLC (KBI Biopharma Inc), Waisman Center (Waisman Biomanufacturing), Cell and Gene Therapy Catapult, Merck KGaA, Lonza Group, Oxford Biomedica Plc, WuXi AppTec, Charles River Laboratoires International Inc., Institut Merieux (ABL Inc.), BioCentriq, Centre for Commercialization of Regenerative Medicine (CCRM), Fujifilm Holdings Corporation (Fujifilm Cellular Dynamics), Amgen Inc., Bluebird Bio Inc., Takeda Pharmaceutical Company Limited are among the major market players in the global platform that lead the market growth of the global cell therapy manufacturing market.
Years considered for this report:
Historical Years: 2016-2019
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2022–2026
Objective of the Study:
- To analyze and estimate the market size of global cell therapy manufacturing market from 2016 to 2020.
- To estimate and forecast the market size of global cell therapy manufacturing market from 2021 to 2026 and growth rate until 2026.
- To classify and forecast global cell therapy manufacturing market based on therapy, source of cell, scale of operation, source, application, end user, company, and regional distribution.
- To identify dominant region or segment in the global cell therapy manufacturing market.
- To identify drivers and challenges for global cell therapy manufacturing market.
- To examine competitive developments such as expansions, mergers & acquisitions, etc., in global cell therapy manufacturing market.
- To identify and analyze the profile of leading players operating in global cell therapy manufacturing market.
- To identify key sustainable strategies adopted by market players in global cell therapy manufacturing market.
TechSci Research calculated the market size of global cell therapy manufacturing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Companies, and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to cell therapy manufacturing
- Market research and consulting firms
Report Scope:
In this report, global cell therapy manufacturing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Global Cell Therapy Manufacturing Market, By Therapy:
- T-Cell Therapies
- Dendritic Cell Therapies
- Tumor Cell Therapies
- Stem Cell Therapies
- Global Cell Therapy Manufacturing Market, By Source of Cell:
- Autologous
- Allogenic
- Global Cell Therapy Manufacturing Market, By Scale of Operation:
- Preclinical
- Clinical
- Commercial
- Global Cell Therapy Manufacturing Market, By Source:
- In-House
- Contract Manufacturing
- Global Cell Therapy Manufacturing Market, By Application:
- Oncology
- Cardiovascular Diseases
- Orthopedic Diseases
- Others
- Global Cell Therapy Manufacturing Market, By End User:
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
- Global Cell Therapy Manufacturing Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
- Asia-Pacific
- China
- Japan
- South Korea
- Australia
- India
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Israel
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in global cell therapy manufacturing market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1.Novartis AG
2.F. Hoffmann La Roche AG
3.Gilead Sciences, Inc.
4.Thermo Fischer Scientific, Inc.
5.Catalent, Inc.
6.JSR Life Sciences LLC (KBI Biopharma Inc)
7.Waisman Center (Waisman Biomanufacturing)
8.Cell and Gene Therapy Catapult
9.Merck KGaA
10.Lonza Group
11.Oxford Biomedica Plc
12.WuXi AppTec
13.Charles River Laboratories International Inc.
14.Institut Merieux (ABL Inc.)
15.BioCentriq
16.Centre for Commercialization of Regenerative Medicine (CCRM)
17.Fujifilm Holdings Corporation (Fujifilm Cellular Dynamics)
18.Amgen Inc.
19.Bluebird Bio Inc.
20.Takeda Pharmaceutical Company Limited
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights
- 1. Product Overview
- 2. Research Methodology
- 3. Executive Summary
- 4. Impact of COVID-19 on Global Cell Therapy Manufacturing Market
- 5. Voice of Customers
- 5.1. Brand Awareness
- 5.2. Commonly Used Cell Therapies
- 5.3. Preferences Based on Source of Cell Among Medical Professionals
- 6. Global Cell Therapy Manufacturing Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies)
- 6.2.2. By Source of Cell (Autologous v/s Allogenic)
- 6.2.3. By Scale of Operation (Preclinical, Clinical, Commercial)
- 6.2.4. By Source (In-House v/s Contract Manufacturing)
- 6.2.5. By Application (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Others)
- 6.2.6. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)
- 6.2.7. By Company (2020)
- 6.2.8. By Region
- 6.3. Product Market Map
- 6.3.1. By Therapy
- 6.3.2. By Scale of Operation
- 6.3.3. By Source
- 6.3.4. By Application
- 6.3.5. By Region
- 7. North America Cell Therapy Manufacturing Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Therapy
- 7.2.2. By Source of Cell
- 7.2.3. By Scale of Operation
- 7.2.4. By Source
- 7.2.5. By Application
- 7.2.6. By End User
- 7.2.7. By Country
- 7.3. North America: Country Analysis
- 7.3.1. United States Cell Therapy Manufacturing Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Therapy
- 7.3.1.2.2. By Source of Cell
- 7.3.1.2.3. By Scale of Operation
- 7.3.1.2.4. By Source
- 7.3.1.2.5. By Application
- 7.3.1.2.6. By End User
- 7.3.2. Canada Cell Therapy Manufacturing Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Therapy
- 7.3.2.2.2. By Source of Cell
- 7.3.2.2.3. By Scale of Operation
- 7.3.2.2.4. By Source
- 7.3.2.2.5. By Application
- 7.3.2.2.6. By End User
- 7.3.3. Mexico Cell Therapy Manufacturing Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Therapy
- 7.3.3.2.2. By Source of Cell
- 7.3.3.2.3. By Scale of Operation
- 7.3.3.2.4. By Source
- 7.3.3.2.5. By Application
- 7.3.3.2.6. By End User
- 8. Europe Cell Therapy Manufacturing Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Therapy
- 8.2.2. By Source of Cell
- 8.2.3. By Scale of Operation
- 8.2.4. By Source
- 8.2.5. By Application
- 8.2.6. By End User
- 8.2.7. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. Germany Cell Therapy Manufacturing Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Therapy
- 8.3.1.2.2. By Source of Cell
- 8.3.1.2.3. By Scale of Operation
- 8.3.1.2.4. By Source
- 8.3.1.2.5. By Application
- 8.3.1.2.6. By End User
- 8.3.2. France Cell Therapy Manufacturing Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Therapy
- 8.3.2.2.2. By Source of Cell
- 8.3.2.2.3. By Scale of Operation
- 8.3.2.2.4. By Source
- 8.3.2.2.5. By Application
- 8.3.2.2.6. By End User
- 8.3.3. United Kingdom Cell Therapy Manufacturing Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Therapy
- 8.3.3.2.2. By Source of Cell
- 8.3.3.2.3. By Scale of Operation
- 8.3.3.2.4. By Source
- 8.3.3.2.5. By Application
- 8.3.3.2.6. By End User
- 8.3.4. Spain Cell Therapy Manufacturing Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Therapy
- 8.3.4.2.2. By Source of Cell
- 8.3.4.2.3. By Scale of Operation
- 8.3.4.2.4. By Source
- 8.3.4.2.5. By Application
- 8.3.4.2.6. By End User
- 8.3.5. Italy Cell Therapy Manufacturing Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Therapy
- 8.3.5.2.2. By Source of Cell
- 8.3.5.2.3. By Scale of Operation
- 8.3.5.2.4. By Source
- 8.3.5.2.5. By Application
- 8.3.5.2.6. By End User
- 9. Asia-Pacific Cell Therapy Manufacturing Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Therapy
- 9.2.2. By Source of Cell
- 9.2.3. By Scale of Operation
- 9.2.4. By Source
- 9.2.5. By Application
- 9.2.6. By End User
- 9.2.7. By Country
- 9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Cell Therapy Manufacturing Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Therapy
- 9.3.1.2.2. By Source of Cell
- 9.3.1.2.3. By Scale of Operation
- 9.3.1.2.4. By Source
- 9.3.1.2.5. By Application
- 9.3.1.2.6. By End User
- 9.3.2. Japan Cell Therapy Manufacturing Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Therapy
- 9.3.2.2.2. By Source of Cell
- 9.3.2.2.3. By Scale of Operation
- 9.3.2.2.4. By Source
- 9.3.2.2.5. By Application
- 9.3.2.2.6. By End User
- 9.3.3. South Korea Cell Therapy Manufacturing Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Therapy
- 9.3.3.2.2. By Source of Cell
- 9.3.3.2.3. By Scale of Operation
- 9.3.3.2.4. By Source
- 9.3.3.2.5. By Application
- 9.3.3.2.6. By End User
- 9.3.4. Australia Cell Therapy Manufacturing Market Outlook
- 9.3.4.1. Market Size & Forecast
- 9.3.4.1.1. By Value
- 9.3.4.2. Market Share & Forecast
- 9.3.4.2.1. By Therapy
- 9.3.4.2.2. By Source of Cell
- 9.3.4.2.3. By Scale of Operation
- 9.3.4.2.4. By Source
- 9.3.4.2.5. By Application
- 9.3.4.2.6. By End User
- 9.3.5. India Cell Therapy Manufacturing Market Outlook
- 9.3.5.1. Market Size & Forecast
- 9.3.5.1.1. By Value
- 9.3.5.2. Market Share & Forecast
- 9.3.5.2.1. By Therapy
- 9.3.5.2.2. By Source of Cell
- 9.3.5.2.3. By Scale of Operation
- 9.3.5.2.4. By Source
- 9.3.5.2.5. By Application
- 9.3.5.2.6. By End User
- 10. South America Cell Therapy Manufacturing Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Therapy
- 10.2.2. By Source of Cell
- 10.2.3. By Scale of Operation
- 10.2.4. By Source
- 10.2.5. By Application
- 10.2.6. By End User
- 10.2.7. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Cell Therapy Manufacturing Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Therapy
- 10.3.1.2.2. By Source of Cell
- 10.3.1.2.3. By Scale of Operation
- 10.3.1.2.4. By Source
- 10.3.1.2.5. By Application
- 10.3.1.2.6. By End User
- 10.3.2. Argentina Cell Therapy Manufacturing Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Therapy
- 10.3.2.2.2. By Source of Cell
- 10.3.2.2.3. By Scale of Operation
- 10.3.2.2.4. By Source
- 10.3.2.2.5. By Application
- 10.3.2.2.6. By End User
- 10.3.3. Colombia Cell Therapy Manufacturing Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Therapy
- 10.3.3.2.2. By Source of Cell
- 10.3.3.2.3. By Scale of Operation
- 10.3.3.2.4. By Source
- 10.3.3.2.5. By Application
- 10.3.3.2.6. By End User
- 11. Middle East and Africa Cell Therapy Manufacturing Market Outlook
- 11.1. Market Size & Forecast
- 11.1.1. By Value
- 11.2. Market Share & Forecast
- 11.2.1. By Therapy
- 11.2.2. By Source of Cell
- 11.2.3. By Scale of Operation
- 11.2.4. By Source
- 11.2.5. By Application
- 11.2.6. By End User
- 11.2.7. By Country
- 11.3. MEA: Country Analysis
- 11.3.1. Israel Cell Therapy Manufacturing Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.1.1. By Value
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Therapy
- 11.3.1.2.2. By Source of Cell
- 11.3.1.2.3. By Scale of Operation
- 11.3.1.2.4. By Source
- 11.3.1.2.5. By Application
- 11.3.1.2.6. By End User
- 11.3.2. South Africa Cell Therapy Manufacturing Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.1.1. By Value
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Therapy
- 11.3.2.2.2. By Source of Cell
- 11.3.2.2.3. By Scale of Operation
- 11.3.2.2.4. By Source
- 11.3.2.2.5. By Application
- 11.3.2.2.6. By End User
- 11.3.3. Saudi Arabia Cell Therapy Manufacturing Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.1.1. By Value
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Therapy
- 11.3.3.2.2. By Source of Cell
- 11.3.3.2.3. By Scale of Operation
- 11.3.3.2.4. By Source
- 11.3.3.2.5. By Application
- 11.3.3.2.6. By End User
- 11.3.4. UAE Cell Therapy Manufacturing Market Outlook
- 11.3.4.1. Market Size & Forecast
- 11.3.4.1.1. By Value
- 11.3.4.2. Market Share & Forecast
- 11.3.4.2.1. By Therapy
- 11.3.4.2.2. By Source of Cell
- 11.3.4.2.3. By Scale of Operation
- 11.3.4.2.4. By Source
- 11.3.4.2.5. By Application
- 11.3.4.2.6. By End User
- 12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
- 13. Market Trends & Developments
- 14. Clinical Trials
- 15. Patent Analysis
- 16. Competitive Landscape
- 16.1. Competition Outlook
- 16.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
- 16.2.1. Novartis AG
- 16.2.2. F. Hoffmann La Roche AG
- 16.2.3. Gilead Sciences, Inc.
- 16.2.4. Thermo Fischer Scientific, Inc.
- 16.2.5. Catalent, Inc.
- 16.2.6. JSR Life Sciences LLC (KBI Biopharma Inc)
- 16.2.7. Waisman Center (Waisman Biomanufacturing)
- 16.2.8. Cell and Gene Therapy Catapult
- 16.2.9. Merck KGaA
- 16.2.10. Lonza Group
- 16.2.11. Oxford Biomedica Plc
- 16.2.12. WuXi AppTec
- 16.2.13. Charles River Laboratories International Inc.
- 16.2.14. Institut Merieux (ABL Inc.)
- 16.2.15. BioCentriq
- 16.2.16. Centre for Commercialization of Regenerative Medicine (CCRM)
- 16.2.17. Fujifilm Holdings Corporation (Fujifilm Cellular Dynamics)
- 16.2.18. Amgen Inc.
- 16.2.19. Bluebird Bio Inc.
- 16.2.20. Takeda Pharmaceutical Company Limited
- 17. Strategic Recommendations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook